|
SETD1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.431200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.149400E-01 |
| Normal-vs-Stage2 |
7.374400E-01 |
| Normal-vs-Stage3 |
8.068200E-01 |
| Normal-vs-Stage4 |
5.631600E-01 |
| Stage1-vs-Stage2 |
1.417830E-01 |
| Stage1-vs-Stage3 |
7.099900E-02 |
| Stage1-vs-Stage4 |
4.941500E-02 |
| Stage2-vs-Stage3 |
8.953000E-01 |
| Stage2-vs-Stage4 |
8.589600E-01 |
| Stage3-vs-Stage4 |
7.147600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.821800E-01 |
| Normal-vs-AfricanAmerican |
1.531160E-01 |
| Normal-vs-Asian |
2.125600E-02 |
| Caucasian-vs-AfricanAmerican |
7.943800E-02 |
| Caucasian-vs-Asian |
2.857700E-02 |
| AfricanAmerican-vs-Asian |
2.377000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.650200E-01 |
| Normal-vs-Female |
7.992500E-02 |
| Male-vs-Female |
2.695900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.486000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.898790E-01 |
| Normal-vs-Age(61-80Yrs) |
8.252600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.463600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.366000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.379800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.140600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.697900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.259650E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.357000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.244820E-03 |
| Normal-vs-Grade 2 |
1.916240E-01 |
| Normal-vs-Grade 3 |
8.388800E-01 |
| Normal-vs-Grade 4 |
2.499600E-01 |
| Grade 1-vs-Grade 2 |
2.222700E-03 |
| Grade 1-vs-Grade 3 |
1.079330E-03 |
| Grade 1-vs-Grade 4 |
1.162360E-04 |
| Grade 2-vs-Grade 3 |
5.059700E-02 |
| Grade 2-vs-Grade 4 |
7.902100E-03 |
| Grade 3-vs-Grade 4 |
2.580400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.942800E-01 |
| Normal-vs-ccB subtype |
9.613400E-01 |
| ccA subtype-vs-ccB subtype |
1.600950E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.829200E-01 |
| Normal-vs-N1 |
8.422000E-01 |
| N0-vs-N1 |
9.612000E-01 |
|
|
